Plasma from hemodialysis patients evoked weak photon emissions (chemiluminescence) in a characteristic emission spectrum with a peak at 430 nm, attributed to attack by hydroxyl radicals generated from the iron-catalyzed breakdown of hydrogen peroxide (Fenton reaction), whereas plasma from normal healthy subjects showed a rather weak red chemiluminescence peak at around 680 nm, similar to that resulting from attack by hydroxyl radicals. However, the addition of hydrogen peroxide in the absence of divalent irons induced almost the same red chemiluminescent emission spectrum in both plasmas. The HPLC-gel-filtration chromatography carried out with both plasmas revealed that a primary emitter evoking a peak emission at 430 nm was located in the fraction of lower-molecular-mass substances in fractionated plasma from hemodialysis patients. In contrast, the elution peaks evoking red chemiluminescence with the addition of hydrogen peroxide were mainly observed for the highermolecular-mass fraction, as determined by gel chromatography of both plasmas. Therefore, the observation of a chemiluminescence peak at 430 nm, induced by the generation of hydroxyl radicals, correlated well with chemiluminescent emissions in plasma samples from patients with chronic renal failure. Spectral analyses of clinical samples that show weak chemiluminescence by forced oxidation by such an active oxygen may provide a new and more sensitive method for diagnosing metabolic disorders. samples were separated by reversed-phase HPLC, and some fluorescent compounds were identified as indole derivatives (5). These reports predicted that the molecular size of such fluorescent compounds was probably <1000 Da (3); however, in one case, such a fluorescent compound was tightly bound to serum albumin (2, 6). According to these reports, such fluorescent compounds are generally increased in sera from uremic patients with chronic renal failure (1, 2, 3, 5) ; therefore, these fluorescent compounds are assumed to particularly accumulate in blood of patients with chronic renal failure.
ular size of such fluorescent compounds was probably <1000 Da (3); however, in one case, such a fluorescent compound was tightly bound to serum albumin (2, 6). According to these reports, such fluorescent compounds are generally increased in sera from uremic patients with chronic renal failure (1, 2, 3, 5); therefore, these fluorescent compounds are assumed to particularly accumulate in blood of patients with chronic renal failure.
Rhee et al. (7) found that serum from patients with chronic renal failure contained a substance(s) that potentially enhances the oxidative metabolism of polymorphonuclear leukocytes. During hemodialysis therapies a mechanical stimulation of polymorphonuclear leukocytes may occur. Therefore, one reason why large amounts of fluorescent compounds accumulate in the blood of patients with chronic renal failure may be the oxidative production of these compounds by the generation of active oxygen species from the activated polymorphonuclear leukocytes, whether by the potential enhancer/stimulator or by mechanical stimulation during hemodialysis. It has been reported that methylguanidine (8) is increased in uremic sera from patients with chronic renal failure, a finding that supports such a stimulation mechanism during hemodialysis. For example, increased !32-microglobulin in hemodialysis patients (9, 10) is considered to result in amyloid deposits, in association with active oxygens.
However, an accumulation of such fluorescent compounds in uremic sera is mainly due to incomplete clearance in renal failure; a linear correlation between the fluorescent compounds and creatiine concentrations supports this explanation (11) . Detailed information concerning the molecular structure and physicochemical properties of such fluorescent compounds has yet to be obtained.
On the other hand, we reported previously that a very weak chemiluminescence from the plasma of hemodialysis patients, in comparison with that in normal subjects, was greatly enhanced under alkaline conditions (pH 9-12) (12) . However, such enhanced chemiluminescence in plasma from hemodialysis patients provided a nonspecific emission spectrum that greatly resembles that from normal subjects, despite the difference in emission intensities. Such alkaline-enhanced chemiluminescent factors were separated by HPLC-gel chromatography of hemodialysis patient's plasma. One of the factors specifically appeared in the middle-molecular-mass fraction; with normal subjects' plasma, such a chemiluminescent factor is absent in the same fraction ( 
13).
Recently we have observed that, in the plasma of hemodialysis patients, weak chemiluminescence (characteristic spectral peak, 430 nm) is induced by the attack of hydroxyl radicals generated from the decomposition of hydrogen peroxide in the presence of divalent irons (Fenton reaction) (14, 15) . To examine the potential relationship of a chemiluminescent substance having a peak at 430 nm with the blue fluorescent compounds observed on the HPLC-gel chromatography of the plasma of hemodialysis patients, we examined the absorption, fluorescence, and elution patterns of these compounds.
Having found a chemiluminescent factor induced by the attack of hydroxyl radicals in the low-molecularmass-fraction substances after separation of the plasma by gel chromatography, we concluded that the factor had a different molecular mass from that of the alkaline-enhanced chemiluminescence appearing in the middle-molecular-mass fraction.
Materials and Methods
Samples. Plasma was obtained from blood taken from normal healthy subjects and hemodialysis patients after centrifugation to remove blood cells, according to ordinary methods (12) . Plasma from the patients and from the healthy subjects was then pooled separately, after each individual plasma had been examined for chemiluminescent properties. Using a Centriflow CF-25 (Amicon, Beverly, MA), we obtained ultrafiltrates from a hemodialysis patient, from whom plasma was also taken, for comparison of the dialyzability of the chemiluminescent substances. The plasmas obtained were stored frozen (-20 #{176}C) until used. Urine samples from normal healthy subjects were pooled for analysis by HPLC-gel chromatography.
Gel chromatography. For HPLC-gel-flltration chromatography (Model 880-PU; JASCO, Tokyo, Japan), a gel column (Asahi Pak GS 520P; 2.15 x 50 cm) was equilibrated with 67 mmoIJL phosphate buffer, pH 7.2, containing 100 mmol of NaC1, 0.1 mmol of EDTA, and 0.1 mniol of dithiothreitol (D'J.T) per liter; this prevented autoxidation of plasma samples. The respective pooled plasma samples (1 mL) were applied to the column and eluted with the same buffer. Elution patterns were recorded by monitoring ultraviolet absorption at 280 nm and fluorescent emissions at 430, 460, and 700 nm, after excitation at various wavelengths. Before the plasma samples were applied to the column, the standard molecular mass markers were chromatographed to define the eluting positions (see Figure 4A) .
At the same time, the chemiluminescence emissions induced by hydrogen peroxide with iron sulfate (FeSO4) or by hydrogen peroxide without iron sulfate were measured by a photon-counting-type photomultiplier (R1333; Hamamatsu Photonics) at the mixing port by mixing 882 mmol/L hydrogen peroxide and 2 mmol/L iron sulfate solutions with the eluants from the gel column. We used either an interference filter (Toshiba, Tokyo, Japan) centered at 430 nm (39% transmittance, 18-nm half-width) or a filter to cut off emissions <610 nm (Toshiba). Before mixing the solutions, we agitated the iron sulfate solution with argon gas to deplete the supply of dissolved free oxygen to prevent autoxidation of divalent iron ions (Fe2).
The flow rate for separation of samples on the gel column was 2.7 mlJmin in one line; the other two lines, the iron sulfate solution and the hydrogen peroxide in distilled water, flowed at 1.0 mL/min. The line for the iron sulfate solution was closed when we measured the elution pattern for chemiluminescence induced by the addition of hydrogen peroxide without iron sulfate.
Chemiluminescence measurements. The time course of chemiluniinescence induced by the hydroxyl radicals was measured by the injection of 1 mL of hydrogen peroxide solution into a reaction mixture of 1 mL of the plasma sample (after dilution with an equal volume of the phosphate bufferfEDTAlDrr solution) and 1 mL of 2 mmol/L iron sulfate solution. The face of the reaction vessel was placed at the photon-counting photomultiplier window (12) , which was covered with the same filters as used in HPLC-gel chromatography.
All chemiluminescence measurements were carried out at 25 #{176}C. Measurement of chemiluminescence in the effluents from the HPLC-gel chromatography was carried out by using the mixing port as described already, in which the effluent, the hydrogen peroxide solution, and the iron sulfate solution were mixed from three flow lines, and drained in one line, concomitant with the measurement of chemiluminescence.
This mixing port also faced the photomultiplier (12) , and the changes in chemiluminescence intensities were recorded and stored in a microcomputer-controlled system. The measurements of chemiluminescence intensities of the respective plasma samples at 430 nm (or in the red wavelength region) were accomplished by the same flow system but without a gel column. Before application of the samples, 0.5 mL of plasma was diluted with 2 mL of the phosphate buffer/EDTAJDTI', pH 7.2. The other conditions were the same as for chemiluminescence measurement after HPLC-gel chromatography.
Spectral analyses of chemiluminescence. The emission spectra obtained from weak chemiluminescence in plasma by the attack of hydroxyl radicals or with the addition of the hydrogen peroxide were analyzed with a polychromatic spectrometer recently developed in our laboratory (Nagoshi et al., in press). This polychromatic spectrometer has a time resolution of 1 s and can detect the simultaneous changes in chemiluminescent emission intensities at wavelengths between 400 and 800 nm; thus, it can trace the rapid change of spectral proffles, reflecting the rapid increase or rapid decay in emission intensity. Therefore, the spectral measurements were carried out for 10 s at 25 #{176}C after initiation of the chemiluminescence reaction. The reaction for spectral analysis was initiated by adding 1 mL of hydrogen peroxide solution to 1 inL of diluted whole >. (Before this addition, the plasma samples had been diluted with an equal volume of the phosphate/EDTA/DTI' buffer, pH 7.2.) To measure the spectra after the addition of hydrogen peroxide, we added 1 mL of distilled water instead of iron sulfate solution to the mixture. To compare the spectral profiles, we added 1 mL of 20 kU/L horseradish peroxidase reagent, instead of iron sulfate, to the reaction mixtures.
Reagents.
Hydrogen peroxide was obtained from Santoku Chemicals, Tokyo, Japan. Iron sulfate was purchased from Wako Pure Chemicals, Osaka, Japan.
Horseradish peroxidase was obtained from Sigma Chemicals, St. Louis, MO. The other reagents used were of analytical grade.
ResuIts
In the pooled plasma from the normal healthy subjects and the hemodialysis patients, the red chemiluminescent emission spectra (peak ---680 nm) were induced by the addition of hydrogen peroxide at pH 7.2 ( Figure  1 ). The spectral proffles obtained from both kinds of plasma clearly differed from those obtained under alkaline conditions (13) . However, no significant difference was found in spectra of the plasma from normal healthy subjects ( Figure   1 , curve A) or hemodialysis patients (Figure 1 , curve B), except that a small emission peak at 430 nm appeared in the plasma of hemodialysis patients (Figure 1, curve B) , upon introduction of the hydrogen peroxide. The decay rates for both peak intensities in chemiluminescent emission spectra seemed almost the same, at least during spectral analysis (data not shown).
When the same amount of hydrogen peroxide was added to the plasma sample in the presence of iron sulfate (Figure 2 ), the plasma from the hemodialysis patients showed a clear emission peak at 430 rim, with a second small peak near 680 mu appearing immediately after the initiation of this reaction (Figure 2, by the hydroxyl radicals that were generated from the breakdown of hydrogen peroxide catalyzed by the divalent iron (14, 15) .
In the plasma of normal subjects, however, the main peak at 430 nm did not appear upon attack by hydroxyl radicals; instead, a broad emission spectrum possessing a peak at -680 rim appeared (curve A in Figure 2 ) and resembled the chemilurninescent spectrum induced by the addition of hydrogen peroxide only (see Figure 1) . The difference of chemiluminescent spectra initiated by hydroxyl radicals-between the blue emission (430 rim) in the plasma of hemodialysis patients and the red emission (--680 nm) in plasmas of both normal subjects and hemodialysis patients-indicated that the species of the primary emitter(s) eliciting chemiluminescence with the hydroxyl radicals were completely different. Moreover, addition of peroxidase instead of iron sulfate in the presence of hydrogen peroxide showed a very weak chexniluminescence between 500 and 600 rim (data not shown). This finding suggests that the divalent iron added to the reaction mixtures probably does not act in the same way as the peroxidase. Because we observed no peak emission at 430 nm in the plasma of normal healthy subjects, the accumulation of such emitter(s) in the plasma of hemodialysis patients may reflect a metabolic disorder, perhaps related to chronic renal failure.
Aside from the decay of the peak intensities in the chemiluminescence spectra, the time courses of chemiluminescence emission intensities induced by hydroxyl radicals or with the addition of hydrogen peroxide were measured further in both plasmas, with use of an interference filter at 430 nm and a cutoff filter for emissions <610 nm for the measurement of peak emissions at --680 nm, respectively (Figure 3) . The hydroxyl radical-induced chemiluminescence intensity at 430 rim showed a rapid increase, followed by a subsequent faster decay with a second slow decay phase, in the plasma of hemodialysis patients ( Figure 3A, curve 1) . However, in the plasma of normal healthy subjects ( Figure 3A , curve 2), only a slow decay phase was observed, similar to the second decay phase in the plasma of hemodialysis patients. For red emissions induced by the addition of hydrogen peroxide with iron sulfate, a rapid increase followed by a slow decay in chemiluminescence intensity was observed in both kinds of plasma ( Figure 3B) . The difference between chemiluminescence intensities observed at 430 mu and those in the red wavelength region is due to transmittance in the filters used. On the basis of the decay kinetics, we suggest that two emitters eliciting chemiluminescence at 430 nm are present in the whole plasma of hemodialysis patients, but in the plasma of normal healthy subjects no emitter at 430 urn is identified by the spectral analysis (see Figure 2A ). In comparison with the chemiluminescence intensities appearing in Figure 3 (A and B) , the emitter(s) in the red wavelength region showed a decay profile different from that at 430 nm, despite having the same initiation of chemiluminescence by the hydroxyl radicals.
On the other hand, after the addition of hydrogen peroxide, the intensities of chemiluminescence in the red wavelength region showed a slower decay in the second phase in the plasma of hemodialysis patients (curve 1 in Figure 3C ) than in the normal healthy Figure 3C ). It seems likely that the decay rates in the second phase of both kinds of plasma samples are different. A similar proffle for decay of chemiluminescence intensities was also observed in both plasmas at 430-mu emissions induced by the addition of hydrogen peroxide ( Figure 3D) . Therefore, the proffle for decay observed in Figure 3D may reflect the tailing emissions of red chemiluminescence (peak at -680 mu). Conversely, a small peak at 430 rim, appearing in the spectrum of hemodialysis patients' plasma to which hydrogen peroxide had been added (Figure 1,  curve A) , could not be explained on the basis of the decay kinetics.
The presence of the emitter of hydroxyl radical-induced chemiluminescence was further identified in the fractionation of the plasma by HPLC-gel chromatography. As shown in Figure 4 , the elution patterns were measured by their ultraviolet absorption at 280 mu ( Figure 4A ) and by their fluorescent emissions at 430 rim ( Figure 4B ) and 700 mu ( Figure 4C ) after excitation at 275 and 300 mu, respectively. Chemiluminescent emissions were measured through 430-nm filters (Figure 4D) showed that for samples from normal healthy subjects chemlluminescenceelutlon pattern of urine from normal healthy subjects. The fractionation by gel chromatography of both kinds of plasma samples further revealed that emitters eliciting chemiluminescence with the addition of hydrogen peroxide were different from those emitted at 430 mu induced by hydroxyl radicals. As shown in Figure  4F , hydrogen peroxide-reactive chemiluminescent emitters were also located in the high-molecular-mass fraction for plasma from both normal subjects and hemodialysis patients. However, such an emitter in the highmolecular-mass fraction showed elution patterns that were somewhat different from the hydroxyl radicalreactive emitters measured in the red wavelength region in both plasmas (compare Figure 4, E and F) . We suggest that the high-molecular-mass fractions evoking red chemiluminescent emissions in the presence of hydroxyl radicals or of hydrogen peroxide involve different types of emitters, which are located close together in the high-molecular-mass fractions. The first red fluorescent peak appearing in Figure 4C According to the results of chemiluminescence properties of the effluent after the HPLC-gel chromatography, the chemilwninescent emission spectra induced by hydroxyl radicals were confirmed agai&in the fractionated samples. As shown in Figure 5 , curve B, in the low-molecular-mass fraction, a spectral emission peaking at 430 rim indeed appeared after the attack by hydroxyl radicals, whereas the red emission (peak -680 urn) was not involved in this spectrum. For the same fraction from the normal healthy subjects, no such 430-nm peak emission could be detected ( Figure 5, curve A) .
On the contrary, in the high-molecular-mass fractions, a red chemiluminescent emission was observed when a cutoff filter was used; the emission spectrum with a peak at 680 mu but without a peak at 430 mu was obtained in fractionated plasma from both normal healthy subjects and hemodialysis patients (data not shown). As shown in Figure 4 , the elution pattern of the red chemiluminescent emissions showed two or three peaks in the high-molecular-size fractions; therefore, such an emission spectrum may comprise a mixture of different kinds of emitter molecules eliciting chemiluminescence at closely neighboring wavelengths in the red wavelength region. We established, however, that two chemiluminescent emission peaks (at blue and red wavelengths) observed for whole plasma were completely separated by gel-filtration chromatography. This observation confirmed that two groups of emitter molecules separately possessed the different emission properties and the different molecular sizes. For the chemiluminescent spectrum in high-molecular-mass fractions, induced by the addition of hydrogen peroxide, the spectral profile was similar to that induced by the hydroxyl radicals (data not shown).
Gel chromatography of ultrafiltrates from hemodialysis patients also showed the blue chemiluininescent emissions in the low-molecular-mass fractions after induction by hydroxyl radicals (data not shown). As shown by gel chromatography (Figure 4) , an emitter at the 430-mu peak was included in the low-molecular-mass fraction, and thus was dialyzed easily in the hemodial-
However, the other emitters eliciting the red emissions, i.e., the hydroxyl radical-reactive emitter at 680 mu and the hydrogen peroxide-reactive emitters, could not be found in the ultrauiltrates of either kind of plasma, because these emitters might be involved with the undialyzable high-molecular-mass substances.
The elution pattern of urine from the normal healthy subjects upon HPLC-gel chromatography also showed the peak of chemiluminescent emissions induced by hydroxyl radicals in the same low-molecular-mass fractions; however, this elution pattern was slightly different from that for the plasma of the hemodialysis patients as evidenced by the appearance of a second small elution peak in the low-molecular-mass fraction (see Figure 4D , curve c). This indicates that a substance that emits at 430 mu is produced and excreted in the urine of the normal healthy subjects; in the subjects with renal failure, such an emitter is accumulated in blood, owing to insufficient clearance by the kidney. Figure 6 shows the chemiluminescence intensities induced by hydroxyl radicals in plasma samples from both normal healthy subjects and hemodialysis patients, as measured at 430 urn and in the red wavelength regions with use of the filters. The plasma samples from hemodialysis patients showed relatively higher chemiluminescence intensities at 430 mu than did those from normal healthy subjects ( Figure 6A ). Weak intensities of chemiluminescence at 430 urn were observed even in plasma from normal healthy subjects, although an emission peak at 430 mu was not detected in the spectrum. Such weak chemiluminescence at 430 mu appearing in the whole plasma samples from normal healthy subjects may reflect the slow decay phase observed in Figure 3A . This emitter eliciting weak chemiluminescence at the blue wavelength region (430 rim) may be involved in the fraction of high-molecularmass substances (see Figure 4D) . However, the mean ± SD(P <0.01) calculated from chemiluminescent intensities of the samples were 1104 ± 261 counts/s for the normal healthy subjects and 8398 ± 7011 for the hemodialysis patients, statistically significantly different intensities. An intense chemiluimnescence at 430 mu, derived from the emitter appearing in the first decay phase in Figure 3A , was specifically observed in the plasma samples of hemodialysis patients.
For measurements of the red emission corresponding to a peak emission at 680 mu in the spectrum induced by the hydroxyl radicals (see Figure 2) , there was no clear difference of chemiluininescence intensities between the two plasmas ( Figure 68 ). Chemiluminescence intensities were 18465 ± 7679 counts/s for the normal healthy subjects and 15829 ± 8760 counts/s for the hemodialysis patients. Such intensities at the red chemiluminescent emissions induced by the addition of hydrogen peroxide were also similar in both plasma samples (data not shown). The higher chemiluminescence intensities at the blue emission (430 mu) were specific to the plasma samples from the hemodialysis patients, in contrast to those at the red emissions, when such chemilumineacence was evoked with the generation of hydroxyl radicals. As shown in Figure 6 , the measurements of is seldom reported (12, 13, 17, 18) and with the addition of hydrogen peroxide. However, these red emissions were not characteristic of the plasma of the hemodialysis patients, in comparison with that of normal healthy subjects. Two or three elution peaks of the red chemiluniinescent emissions in effluents of HPLC-gel chromatography of both kinds of plasmas appeared in the high-molecular-mass fractions (Figure 4, E and F) . Peaks of red emissions in the elution pattern varied slightly, depending upon the active oxygen species at the initiation of chemiluminescent reactions. This finding suggests that emitters evoking the red emissions are present in at least two types, namely, one type of emitter oxidized by hydroxyl radicals, and the other oxidized by added hydrogen peroxide.
Because the emitters eliciting chemiluminescence by the oxidation of active oxygens are the fluorescent compounds considered to be the primary emitters (19), we examined by gel chromatography a coincidence of the fluorescent compounds with such chemiluniinescent emitters. However, the elution patterns of the fluorescent compounds, which were measured by their fluorescences at 430 or 700 urn, were not directly coincident with the elution patterns of chemiluminescent emissions (Figure 4) . Various fluorescent fractions emitting at 415 rim appeared in the gel-chromatography effluents of ultrafiltrates from hemodialysis patients (4). We also observed many fluorescence peaks at 430 mu after gel chromatography of plasma samples from hemodialysis patients. Therefore, as shown by gel chromatography For whole plasma from normal healthy subjects, weak chemiluminescence at 430 mu measured through an interference filter was observed by the oxidation of the hydroxyl radicals ( Figure 6 ). This kind of emitter mol-ecule could not be detected in the low-molecular-mass fraction on gel chromatography; perhaps an emitter at 430 urn was still present in the high-molecular-mass fraction of the plasma of the normal healthy subjects. 
